SCHEMBL17064585

SCHEMBL17064585

Nc1cccc(C(CCC2CC2)c2ccncc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.41
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
KLKB1 P03952 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
GFER P55789 1/20 0.36
CPN1 P15169 1/20 0.35
CPB2 Q96IY4 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
PDE4A P27815 5/20 0.35
PDE4D Q08499 2/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30446809 0.90 HRH1 (0.40) KLKB1MAPTGFERCPN1CPB2
SCHEMBL17064662 0.90 HRH1 (0.40) KLKB1MAPTGFERCPN1CPB2
SCHEMBL17064512 0.86 MEN1 (0.41) MAPKAPK2SLC6A2SLC6A4SLC6A3PDE4A
SCHEMBL30466449 0.86 MEN1 (0.41) MAPKAPK2SLC6A2SLC6A4SLC6A3PDE4A
SCHEMBL17064729 0.80 ALDH1A1 (0.44) SLC6A2SLC6A4SLC6A3MAPTCYP3A4
SCHEMBL17073423 0.76 CPN1 (0.41) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL31067489 0.76 CPN1 (0.41) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL25667743 0.75 CPN1 (0.36) MAPKAPK2SLC6A2SLC6A4SLC6A3CPN1
SCHEMBL22417031 0.74 KLKB1 (0.46) MAPKAPK2KLKB1MAPT
SCHEMBL17064513 0.71 GRIN2B (0.35) SLC6A2SLC6A4SLC6A3MAPTCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113772-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2017-01-11 EP disclosed
WO-2015134998-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2015-09-11 WO disclosed